- sortMedia focus
- auth
- source:
- pubDate2014-06-17 16:12
- Visitas:
[Descripción resumida]"Is it difficult to be a human medicine or a veterinary medicine?" Kang Xianlu, who has transformed from developing "human medicine" to "veterinary medicine", replied that "it is more difficult to make veterinary medicine". Where is the difficulty? "The difficulty is that veterinary drugs can not have the slightest residue, otherwise, people will increase drug resistance after eating animal meat with residual drugs, and the consequences will be 'incurable'.".
Kang Xianlu, a graduate student of Zhejiang University, comes from Chongqing. His fate with Kang Mu originated in 2006. That year, he came from Zhejiang Jingxin Pharmaceutical Co., Ltd. to Zhejiang Kangmu Co., Ltd. as deputy general manager and technical director. "From Chongqing to Zhejiang University, and from Xinchang to Shengzhou, and the company's name is Kang Mu. My last name is Kang. It's really a kind of fate." When it comes to Kang Mu, I can always feel a light shining in Kang Xianlu's eyes.
Since joining Kangmu, kangxianlu has been committed to the company's new product R & D and technological innovation. He focused on the florfenicol production technology project, devoted himself to the development and research, used the methods of finding a large number of relevant international and domestic scientific and technological information and materials, and adopted a large number of trial production and research means such as small-scale test, pilot test and expansion test. He personally did everything from equipment selection to equipment coefficient and formula coefficient. In less than half a year, the new florfenicol process and technology he studied and tested had a significant breakthrough. In order to shorten the process flow, he also perfectly solved the problems such as solvent replacement. Now the product quality is stable, the production cost is greatly reduced, the environmental pollution is reduced, and obvious economic and social benefits have been achieved.
There should be no mistake in the production process, which is Kang Xianlu's requirement for employees. Kang Xianlu always goes to each workshop to have a look at the first thing at work every day. He said that Kangmu's products are mainly chemical synthesis. As the technical manager, he must always master the production dynamics. Even if he hears a slight fluctuation of data in the workshop, it will affect his nerves. "The process of chemical operation is a precise process, and the order of fine to feeding must not be reversed, otherwise the product composition will be changed and the reactor will explode in serious cases."
From the laboratory to the production workshop, Kang Xianlu is not only a developer, but also a gatekeeper. From the feeding sequence, feeding speed and amplification effect, he and his colleagues calculated and demonstrated again and again to accumulate experience in practice. "I came from a technical background. My task is to constantly carry out technological innovation, reduce the labor intensity of workers and ensure safe production." He said that chemical enterprises are different from other enterprises. Once an accident occurs, the consequences are unimaginable. He is most gratified that Kangmu has not had a safety accident in more than eight years.
Today, the annual output of flufenicol API for animals independently developed by Kang Xianlu can reach 600 tons. Both sales and technology rank among the top three in China. It has been listed as a provincial spark project by the Provincial Department of science and technology and a national torch plan project by the Ministry of science and technology. Now, he also reduces COD emissions in the production process by developing new solvents.
During this time, Kang Xianlu was busy with the company's FDA certification. "Now the FDA (US Food and Drug Administration) certification application has been submitted. FDA can be called the most authoritative and strictest pharmaceutical regulatory audit organization in the world. Getting FDA certification is equivalent to getting a pass to enter the European market." Thinking that FDA certification can lead the company to a broader market, he smiled with expectation.
"As a technician in a veterinary medicine enterprise, I have the responsibility to do a good job in veterinary medicine, which is also my mission." When it comes to the future, Kang Xianlu said that he will continue this fate better and be a new Shengzhou person who contributes to the economic development of Shengzhou.
[Descripción resumida]"Is it difficult to be a human medicine or a veterinary medicine?" Kang Xianlu, who has transformed from developing "human medicine" to "veterinary medicine", replied that "it is more difficult to make veterinary medicine". Where is the difficulty? "The difficulty is that veterinary drugs can not have the slightest residue, otherwise, people will increase drug resistance after eating animal meat with residual drugs, and the consequences will be 'incurable'.".
Kang Xianlu, a graduate student of Zhejiang University, comes from Chongqing. His fate with Kang Mu originated in 2006. That year, he came from Zhejiang Jingxin Pharmaceutical Co., Ltd. to Zhejiang Kangmu Co., Ltd. as deputy general manager and technical director. "From Chongqing to Zhejiang University, and from Xinchang to Shengzhou, and the company's name is Kang Mu. My last name is Kang. It's really a kind of fate." When it comes to Kang Mu, I can always feel a light shining in Kang Xianlu's eyes.
Since joining Kangmu, kangxianlu has been committed to the company's new product R & D and technological innovation. He focused on the florfenicol production technology project, devoted himself to the development and research, used the methods of finding a large number of relevant international and domestic scientific and technological information and materials, and adopted a large number of trial production and research means such as small-scale test, pilot test and expansion test. He personally did everything from equipment selection to equipment coefficient and formula coefficient. In less than half a year, the new florfenicol process and technology he studied and tested had a significant breakthrough. In order to shorten the process flow, he also perfectly solved the problems such as solvent replacement. Now the product quality is stable, the production cost is greatly reduced, the environmental pollution is reduced, and obvious economic and social benefits have been achieved.
There should be no mistake in the production process, which is Kang Xianlu's requirement for employees. Kang Xianlu always goes to each workshop to have a look at the first thing at work every day. He said that Kangmu's products are mainly chemical synthesis. As the technical manager, he must always master the production dynamics. Even if he hears a slight fluctuation of data in the workshop, it will affect his nerves. "The process of chemical operation is a precise process, and the order of fine to feeding must not be reversed, otherwise the product composition will be changed and the reactor will explode in serious cases."
From the laboratory to the production workshop, Kang Xianlu is not only a developer, but also a gatekeeper. From the feeding sequence, feeding speed and amplification effect, he and his colleagues calculated and demonstrated again and again to accumulate experience in practice. "I came from a technical background. My task is to constantly carry out technological innovation, reduce the labor intensity of workers and ensure safe production." He said that chemical enterprises are different from other enterprises. Once an accident occurs, the consequences are unimaginable. He is most gratified that Kangmu has not had a safety accident in more than eight years.
Today, the annual output of flufenicol API for animals independently developed by Kang Xianlu can reach 600 tons. Both sales and technology rank among the top three in China. It has been listed as a provincial spark project by the Provincial Department of science and technology and a national torch plan project by the Ministry of science and technology. Now, he also reduces COD emissions in the production process by developing new solvents.
During this time, Kang Xianlu was busy with the company's FDA certification. "Now the FDA (US Food and Drug Administration) certification application has been submitted. FDA can be called the most authoritative and strictest pharmaceutical regulatory audit organization in the world. Getting FDA certification is equivalent to getting a pass to enter the European market." Thinking that FDA certification can lead the company to a broader market, he smiled with expectation.
"As a technician in a veterinary medicine enterprise, I have the responsibility to do a good job in veterinary medicine, which is also my mission." When it comes to the future, Kang Xianlu said that he will continue this fate better and be a new Shengzhou person who contributes to the economic development of Shengzhou.
- sortMedia focus
- auth
- source:
- pubDate2014-06-17 16:12
- Visitas:
"Is it difficult to be a human medicine or a veterinary medicine?" Kang Xianlu, who has transformed from developing "human medicine" to "veterinary medicine", replied that "it is more difficult to make veterinary medicine". Where is the difficulty? "The difficulty is that veterinary drugs can not have the slightest residue, otherwise, people will increase drug resistance after eating animal meat with residual drugs, and the consequences will be 'incurable'.".
Kang Xianlu, a graduate student of Zhejiang University, comes from Chongqing. His fate with Kang Mu originated in 2006. That year, he came from Zhejiang Jingxin Pharmaceutical Co., Ltd. to Zhejiang Kangmu Co., Ltd. as deputy general manager and technical director. "From Chongqing to Zhejiang University, and from Xinchang to Shengzhou, and the company's name is Kang Mu. My last name is Kang. It's really a kind of fate." When it comes to Kang Mu, I can always feel a light shining in Kang Xianlu's eyes.
Since joining Kangmu, kangxianlu has been committed to the company's new product R & D and technological innovation. He focused on the florfenicol production technology project, devoted himself to the development and research, used the methods of finding a large number of relevant international and domestic scientific and technological information and materials, and adopted a large number of trial production and research means such as small-scale test, pilot test and expansion test. He personally did everything from equipment selection to equipment coefficient and formula coefficient. In less than half a year, the new florfenicol process and technology he studied and tested had a significant breakthrough. In order to shorten the process flow, he also perfectly solved the problems such as solvent replacement. Now the product quality is stable, the production cost is greatly reduced, the environmental pollution is reduced, and obvious economic and social benefits have been achieved.
There should be no mistake in the production process, which is Kang Xianlu's requirement for employees. Kang Xianlu always goes to each workshop to have a look at the first thing at work every day. He said that Kangmu's products are mainly chemical synthesis. As the technical manager, he must always master the production dynamics. Even if he hears a slight fluctuation of data in the workshop, it will affect his nerves. "The process of chemical operation is a precise process, and the order of fine to feeding must not be reversed, otherwise the product composition will be changed and the reactor will explode in serious cases."
From the laboratory to the production workshop, Kang Xianlu is not only a developer, but also a gatekeeper. From the feeding sequence, feeding speed and amplification effect, he and his colleagues calculated and demonstrated again and again to accumulate experience in practice. "I came from a technical background. My task is to constantly carry out technological innovation, reduce the labor intensity of workers and ensure safe production." He said that chemical enterprises are different from other enterprises. Once an accident occurs, the consequences are unimaginable. He is most gratified that Kangmu has not had a safety accident in more than eight years.
Today, the annual output of flufenicol API for animals independently developed by Kang Xianlu can reach 600 tons. Both sales and technology rank among the top three in China. It has been listed as a provincial spark project by the Provincial Department of science and technology and a national torch plan project by the Ministry of science and technology. Now, he also reduces COD emissions in the production process by developing new solvents.
During this time, Kang Xianlu was busy with the company's FDA certification. "Now the FDA (US Food and Drug Administration) certification application has been submitted. FDA can be called the most authoritative and strictest pharmaceutical regulatory audit organization in the world. Getting FDA certification is equivalent to getting a pass to enter the European market." Thinking that FDA certification can lead the company to a broader market, he smiled with expectation.
"As a technician in a veterinary medicine enterprise, I have the responsibility to do a good job in veterinary medicine, which is also my mission." When it comes to the future, Kang Xianlu said that he will continue this fate better and be a new Shengzhou person who contributes to the economic development of Shengzhou.